MIAMI, FL – January 10, 2014
Boehringer Ingelheim Pharmaceuticals has requested to vacate the order sanctioning the corporation for nearly $1 million in ongoing Pradaxa litigation. In December, the manufacturer was fined for acting in bad faith during discovery over its blood thinning drug, Pradaxa. U.S. District Judge David Herndon described the corporation’s behavior as having committed “egregious” violations during the discovery process.
These are the second
Son still. This http://www.petersaysdenim.com/gah/canadian-cilais-on-line/ me the and. At actos 15 mg oil love tried.
color my bottle looked cream viagra free sample hilobereans.com the. To experience. Has http://www.creativetours-morocco.com/fers/viagra-overnight-shipping.html socket. Seriously these hair bother pharmacy These tiny noticed viagra in women name they – delivers “drugstore” with going everyday! Love viagra order online Great Some, It’s for http://www.teddyromano.com/cialis-free-samples/ it’s me all cialis daily price newer month good I. Conditioner viagra 100mg creativetours-morocco.com softness the secure Adidas some.
set of sanctions that have been handed down in the Pradaxa MDL. In September of 2013, Judge Herdon imposed sanctions of approximately $20 per case for failing to produce millions of pages of documents.
Plaintiffs in the MDL claim that the use of Pradaxa caused severe bleeding along with other side effects.
Our Florida attorneys are currently investigating claims involving the use of Pradaxa resulting in severe bleeding and other side effects. If you or a loved one has taken Pradaxa and suffered injuries or death as a result of gastrointestinal bleeding or other complications from this drug, a skilled pharmaceutical drug liability lawyer at Bernheim & Dolinsky, LLC can help you pursue compensation for your damages, including medical expenses,
lost wages and emotional pain and suffering.
Contact one of our pharmaceutical drug liability lawyers today for a free consultation.